AirCurve™ 10 CS PaceWave™ - ResMed Middle-East

AirCurve™ 10 CS PaceWave™*

Adaptive servo-ventilator device

The AirCurve 10 CS PaceWave provides you with personalised ASV** therapy to treat your central sleep apnoea, with or without obstructive sleep apnoea, and promote comfort, safety and harmony while you sleep.


ASVAuto mode

ASVAuto mode adapts to your ventilatory and upper airway stability needs on a breath-by-breath basis. By treating breathing disorders with auto-adjusting pressure support and upper airway obstruction with auto-adjusting expiratory positive airway pressure (EPAP), ASVAuto mode rapidly stabilises your respiration.

aircurve 10 cs pacewave


ASV mode

In the PaceWave ASV mode, the EPAP is manually adjusted by your clinician to set the optimal fixed EPAP to keep your airway open.

Other features

  • Easy-Breathe pressure waveform mimics the wave shape of normal breathing and replicates it for your breathing comfort.
  • Continuous leak management enables reliable delivery of therapy pressure while maintaining patient-device synchrony.
  • Climate Control comprises the optional HumidAir™ humidifier and the optional ClimateLineAir™ heated tube and is designed to deliver constant, comfortable temperature and humidity.

Monitor your sleep apnoea therapy with myAir

Take your new beginning in great sleep to the next level with myAir, an exclusive feature available to users of AirSense 10 and AirCurve 10 devices.*



How to buy

Please contact our Customer Service department or your local representative for more information on obtaining ResMed products.


Related products

Motivational data tracking and coaching designed to boost compliance

Read more

Designed to maintain the temperature of the humidified air as it passes through the tube

Read more

Small, quiet and designed for freedom

Read more


* With built-in wireless connectivity.

**ASV therapy is contraindicated in patients with chronic, symptomatic heart failure (NYHA 2-4) with reduced left ventricular ejection fraction (LVEF ≤ 45%) and moderate to severe predominant central sleep apnoea.